Here are five observations:
1. In 2013, the neurosurgery application segment captured the largest image-guided surgery devices market share.
2. The orthopedic surgery application segment is expected to grow at a compound annual growth rate of 7 percent through 2022, the highest of all market segments.
3. The image-guided surgery devices market will grow in North America and Europe, due to adoption of new technologies and access to skilled professionals.
4. The Asia-Pacific region will see the highest growth rate of 6.9 percent through 2022, due to an expanding medical tourism industry and growing government support.
5. Key market players include:
• Analogic Corp. in Peabody, Mass.
• Brainlab in Riem, Germany
• General Electric Company in Fairfield, Conn.
• GSI Group in Assumption, Ill.
• IMRIS in Winnipeg, Canada
• Integra LifeSciences Corp. in Plainsboro, N.J.
• KARL STORZ in Tuttlingen, Germany
• Toshiba Corp. in Tokyo, Japan
• Siemens in Munich, Germany
• Zimmer Biomet in Warsaw, Ind.
• Smith & Nephew in London, England
• St. Jude Medical in St. Paul, Minn.
• Stryker in Kalamazoo, Mich.
• Medtronic in Dublin, Ireland
More articles on devices:
OrthAlign names Eric Timko new CEO and chairman of the board — 4 things to know
Alphatec Spine launches Arsenal Deformity Adolescent Idiopathic Scoliosis system: 5 notes
Globus releases quarterly earnings results — 5 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
